Literature DB >> 12695126

Tumor necrosis factor alpha induces upregulation of CXC-chemokine receptor type II expression and magnifies the proliferative activity of CXC-chemokines in human melanocytes.

Johannes Norgauer1, Stefan Dichmann, Frank Peters, Maja Mockenhaupt, Ingrid Schraufst tter, Yared Herouy.   

Abstract

The CXC-chemokines Groalpha and interleukin-8 (IL-8) are ligands for two different G protein-coupled receptors, named CXC-chemokine receptor I & II (CXCRI & II). Both cytokines are potent growth factors for human melanoma cells, with only limited proliferative activity towards normal melanocytes. Here we analysed the influence of various cytokines on the expression of CXCRI & II and the CXC-chemokine-induced proliferation in human melanocytes. Flow cytometric studies revealed no protein expression of CXCRI and low protein expression of CXCRII at the cell surface of normal melanocytes. Tumor necrosis factor alpha (TNFalpha) enhanced the mRNA and protein expression of CXCRII, but did not influence expression of CXCRI. A consequence of TNFalpha-pretreatment of human melanocytes was a significant enhancement of the proliferative activity of IL-8 and Groalpha. This study implicates that TNFalpha magnifies the biological activity of CXC-chemokines in melanocytes by induction of CXCRII expression.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12695126

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN: 1167-1122            Impact factor:   3.328


  2 in total

1.  Stimulated human melanocytes express and release interleukin-8, which is inhibited by luteolin: relevance to early vitiligo.

Authors:  A Miniati; Z Weng; B Zhang; A Therianou; M Vasiadi; E Nicolaidou; A J Stratigos; C Antoniou; T C Theoharides
Journal:  Clin Exp Dermatol       Date:  2013-06-20       Impact factor: 3.470

2.  IL-17 and TNF synergistically modulate cytokine expression while suppressing melanogenesis: potential relevance to psoriasis.

Authors:  Claire Q F Wang; Yemsratch T Akalu; Mayte Suarez-Farinas; Juana Gonzalez; Hiroshi Mitsui; Michelle A Lowes; Seth J Orlow; Prashiela Manga; James G Krueger
Journal:  J Invest Dermatol       Date:  2013-04-30       Impact factor: 8.551

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.